Literature DB >> 18024647

Comprehensive management of the CLL patient: a holistic approach.

Tait D Shanafelt1, Neil E Kay.   

Abstract

The current management of B-chronic lymphocytic leukemia (CLL) is no longer straightforward for the practicing hematologist. Rapid advances in diagnostic precision, methods of predicting prognosis, understanding of natural history of CLL, recognition of clinical complications, clarification of the quality of life (QOL) issues facing the CLL patient, and the exciting array of novel treatment approaches have made the care of the CLL patient more demanding. This review is focused on summarizing these advances in order to provide a framework for integrating this knowledge into routine hematologic practice.

Entities:  

Mesh：

Year:  2007        PMID： 18024647     DOI： 10.1182/asheducation-2007.1.324

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN： 1520-4383


  6 in total

1.  Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

Authors:  Tait D Shanafelt; Neil E Kay; Kari G Rabe; David J Inwards; Clive S Zent; Jose F Leis; Susan M Schwager; Carrie A Thompson; Deborah A Bowen; Thomas E Witzig; Susan L Slager; Timothy G Call
Journal:  Cancer       Date:  2011-08-26       Impact factor: 6.860

2.  Primary care management of early stage chronic lymphocytic leukaemia is safe and effective.

Authors:  H M Parry; S Damery; N P Mudondo; P Hazlewood; T McSkeane; S Aung; J Murray; G Pratt; P Moss; D W Milligan
Journal:  QJM       Date:  2015-01-31

3.  Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia.

Authors:  Chris L Pashos; Christopher R Flowers; Neil E Kay; Mark Weiss; Nicole Lamanna; Charles Farber; Susan Lerner; Jeff Sharman; David Grinblatt; Ian W Flinn; Mark Kozloff; Arlene S Swern; Thomas K Street; Kristen A Sullivan; Gale Harding; Zeba M Khan
Journal:  Support Care Cancer       Date:  2013-06-08       Impact factor: 3.603

4.  A Canadian perspective on bendamustine for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma.

Authors:  R Van der Jagt; P Laneuville; D Macdonald; D Stewart; A Christofides; L H Sehn
Journal:  Curr Oncol       Date:  2012-06       Impact factor: 3.677

5.  Skin cancer surveillance and malignancies of the skin in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia.

Authors:  Aaron S Mansfield; Kari G Rabe; Susan L Slager; Susan M Schwager; Timothy G Call; Jerry D Brewer; Tait D Shanafelt
Journal:  J Oncol Pract       Date:  2013-08-27       Impact factor: 3.840

6.  Gentle Massage Improves Disease- and Treatment-Related Symptoms in Patients with Acute Myelogenous Leukemia.

Authors:  Ann Gill Taylor; Audrey E Snyder; Joel G Anderson; Cynthia J Brown; John J Densmore; Cheryl Bourguignon
Journal:  J Clin Trials       Date:  2014
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.